ST
Healthcare & Life Sciences
Sanmirna Therapeutics
United Statessanmirna.com
Sanmirna Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A.
Activeseries-a
series-a
Stage
About Sanmirna Therapeutics
Based in the United States, Sanmirna Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences.
Sanmirna Therapeutics is developing microRNA-based therapies targeting leukemia stem cells in Acute Myeloid Leukemia (AML) to overcome treatment resistance, with a lead asset Miristen™ currently in Phase 1 clinical trials in partnership with City of Hope.
Explore Sanmirna Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.